| CAS号 | 名称 | 物化性质 | 分子式 | 分子量 |
| 402567-16-2 | firategrast | |
C27H27F2NO6 | 499.5 |
| 67346-49-0 | (-)-福莫特罗
(r,r)-formoterol | |
| |
| 1228585-88-3 | gs-9620 | |
C22H30N6O2 | 410.51 |
| 943134-39-2 | gap-134 | |
| |
| 405911-09-3 | gw3965 | |
C33H31ClF3NO3 | 582.05 |
| 58020-43-2 | hoku-81 | |
C12H18ClNO2 | 243.73 |
| 914471-09-3 | 4-氨基-n-(3-氯-4-氟苯基)-n'-羟基-1,2,5-恶二唑-3-甲脒
incb024360 analogue | |
C9H7ClFN5O2 | 271.64 |
| 847591-62-2 | pri724 | |
C33H32N4O4 | 548.63 |
| 331963-29-2 | i2906 | |
C25H37N3O4 | 443.58 |
| 176708-42-2 | kn-92 | |
C24H25ClN2O3S | 456.98 |
| 202475-60-3 | 4-(4'-羟基苯基)氨基-6,7-二甲氧基喹唑啉
janex-1 | |
C16H15N3O3 | 297.31 |
| 1234703-40-2 | (1R,2S)-2-环己基-1-[4-(环丙基磺酰基)苯基]-n-[5-[[2-(1-吡咯烷基)乙基]硫代]-2-噻唑基]环丙烷甲酰胺
ly2608204 | |
C28H37N3O3S3 | 559.81 |
| 945976-76-1 | lx-1031 | |
C28H25F3N4O4 | 538.52 |
| 1262036-50-9 | n-[3-[(4as,7as)-2-氨基-4a,5-二氢-4h-呋喃并[3,4-d][1,3]噻嗪-7a(7h)-基]-4-氟苯基]-5-氟-2-吡啶甲酰胺
ly2886721 | |
C18H16F2N4O2S | 390.41 |
| 1206799-15-6 | ly2801653 | |
C30H22F2N6O3 | 552.53 |
| 890087-21-5 | luf6000 | |
C22H20Cl2N4 | 411.33 |
| 496868-77-0 | (2e)-3-(4'-羟基-3'-金刚烷-1-基(1,1'-联苯)-4-基)-2-丙烯酸
adarotene | |
C25H26O3 | 374.47 |
| 1240299-33-5 | azd3514 | |
C25H32F3N7O2 | 519.560 |
| 906673-24-3 | 4-((1,3-二氢-1-羟基-2,1-苯并氧杂硼杂环戊烷-5-基)氧基)苯甲腈
an-2728 | |
C14H10BNO3 | 251.05 |
| 956104-40-8 | arn-509 | |
C21H15F4N5O2S | 477.43 |
| 177707-12-9 | nkp608 | |
C31H24ClF6N3O2 | 619.98 |
| 204697-65-4 | n-[2-[5-氨基-1(S)-[4-(4-吡啶基)哌嗪-1-甲酰基]戊基氨基]-1(R)-(3,5-二溴-4-羟基苄基)-2-氧代乙基]-4-(2-氧代-1,2,3,4-四氢喹唑啉-3-基)哌啶-1-甲酰胺
olcegepant | |
C38H47Br2N9O5 | 869.65 |
| 1290543-63-3 | pf-03084014 hydrobromide | |
C27H41F2N5O | 489.64 |
| 866206-55-5 | prx-08066 maleic acid | |
C19H17ClFN5S·C4H4O4 | 517.96 |
| 143558-00-3 | rocuronium | |
C32H53N2O4 | 529.77 |
| 15585-43-0 | rjr-2403 | |
C10H14N2 | 162.23 |
| 209481-20-9 | sb271046 | |
C20H22ClN3O3S2 | 451.99 |
| 61350-00-3 | n-(3-chlorophenyl)-2-pyridinecarboxamide | |
C12H9ClN2O | 232.67 |
| 249296-44-4 | varenicline | |
C13H13N3 | 211.26 |
| 1246086-78-1 | n-[3-氯-4-[[(2-氯苯基)氨基]磺酰基]苯基]-2-吡啶甲酰胺
vu 0364439 | |
C18H13Cl2N3O3S | 422.29 |
| 155584-74-0 | 2-氯-3-(4-甲基-1-哌嗪基)喹喔啉
vuf 10166 | |
C13H15ClN4 | 262.74 |
| 1289023-67-1 | bms-927711 | |
C28H28F2N6O3 | 534.56 |
| 193611-72-2 | brl-15572 | |
C25H27ClN2O·2HCl | 479.87 |
| 57477-39-1 | 3-(1-甲基-4-哌啶基)-1h-吲哚-5-醇
brl-54443 | |
C14H18N2O | 230.31 |
| 923590-37-8 | vaniprevir | |
C38H55N5O9S | 757.94 |
| 690270-29-2 | balapiravir | |
C21H30N6O8 | 494.5 |
| 193022-04-7 | cts-1027 | |
C19H20ClNO6S | 425.88 |
| 300832-84-2 | ciluprevir | |
C40H50N6O8S | 774.930 |
| 1204144-28-4 | azd-1208；(5z)-5-[[2-[(3R)-3-氨基-1-哌啶基][1,1'-联苯]-3-基]亚甲基]-2,4-噻唑烷二酮
azd1208 | |
C21H21N3O2S | 379.48 |
| 1092499-93-8 | 8-[3,5-二氟-4-(4-吗啉基甲基)苯基]-2-[1-(4-哌啶基)-1h-吡唑-4-基]喹喔啉
nvp-bsk805 2hcl | |
C27H28F2N6O·2HCl | 563.47 |
| 1025065-69-3 | n-[(1-甲基-4-哌啶基)甲基]-3-[3-(三氟甲氧基)苯基]-咪唑并[1,2-b]哒嗪-6-胺
sgi-1776 free base | |
C20H22F3N5O | 405.42 |
| 941685-37-6 | 1h-pyrazole-1-propanenitrile, β-cyclopentyl-4-(7h-pyrrolo[2,3-d]pyrimidin-4-yl)-, (βs)-
s-ruxolitinib (incb018424) | |
C17H18N6 | 306.37 |
| 174636-32-9 | talnetant | |
C25H22N2O2 | 382.45 |
| 1000413-72-8 | (3S)-6-[[2',6'-二甲基-4'-[3-(甲磺酰基)丙氧基][1,1'-联苯]-3-基]甲氧基]-2,3-二氢-3-苯并呋喃乙酸
tak-875 | |
C29H32O7S | 524.63 |
| 1402601-82-4 | tug-770 | |
C19H14FNO2 | 307.32 |
| 701977-09-5 | taranabant | |
C27H25ClF3N3O2 | 515.95 |
| 150683-30-0 | 托伐普坦
tolvaptan | |
| |
| 163521-12-8 | 维拉佐酮
vilazodone | |
C26H27N5O2 | 441.52 |
| 503068-34-6 | 维兰特罗
vilanterol | |
| |
| 162760-96-5 | n-{2-[4-(2-甲氧基苯基)-1-哌嗪基]乙基}-n-(2-吡啶基)环己烷甲酰胺
way-100635 | |
C25H34N4O2 | 422.56 |
